ArticleCancers2024

A Description and Safety Overview of Irreversible Electroporation for Prostate Tissue Ablation in Intermediate-Risk Prostate Cancer Patients: Preliminary Results from the PRESERVE Trial.

Arvin K George et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.